Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

By Stephan Windecker, A. Remondino, F. Eberli, Peter Jüni, L. Räber, P. Wenaweser, M. Togni, M. Billinger, D. Tüller, C. Seiler and 8 more. New England Journal of Medicine, 2005

615 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery

View Paper: https://www.semanticscholar.org/paper/b34e1b908050824ed402cb11b118671b3ce848fa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Hyo‐Soo Kim
2. I. Chae
3. Kyung-Woo Park
4. J. Hahn
5. D. Lim
6. Y. Song
7. Hyun-Jae Kang
8. M. Jeong

Citations in the corpus

• Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study (2012, methodology): “On the basis of data from large, randomized clinical trials evaluating the efficacy of drug-eluting stents, we estimated that the incidence of the primary end point with 12-month DAPT 1 year after the procedure would be 10%.(17,18) The noninferiority margin of 4.”